Brief: Biomed Lublin Signs Annex To Deal With ZF Polpharma

Synthaverse SA

10/08/2022 06:58

Aug 10 (Reuters) - Biomed Lublin Wytwornia Surowic i
Szczepionek SA  BML.WA :
    * SIGNS ANNEX TO DEAL WITH ZAKŁADY FARMACEUTYCZNE POLPHARMA
REGARDING PRODUCTION AND DELIVERY OF LAKCID FORTE
    * ANNEX REGARDS INCREASE IN PRICE
    * THANKS TO ANNEX COMPANY'S REVENUE WILL INCREASE BY ABOUT
1.9
MILLION ZLOTYS IN PERIOD UNTIL END OF CONTRACT (UNTIL END-APRIL
2023)

Source text for Eikon:  ID:nEM1tfP94a 
Further company coverage:  BML.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))